Tschernatsch et al. described three: a subacute SNN with anti-Hu antibodies; a limbic encephalitis with tumor expression of neuronal antigen HuD, which may trigger anti-Hu development; and a paraneoplastic myelitis, also with HuD expression [3]. Here, ELAVL4 is linked to neoplasm.